Peptide Injection Pen

Nuvexa Retatrutide 30mg – Pre-Filled Peptide Injection Pen

Advanced Triple-Agonist Peptide for Metabolic & Weight Management Research

Retatrutide is designed to activate GIP, GLP-1, and glucagon receptors, supporting research into metabolic regulation and energy balance.

Investigated for its potential effects on body weight, glucose regulation, and other metabolic outcomes in clinical studies.

Convenient pre-filled injection-pen presentation designed for subcutaneous administration.

Retatrutide (LY3437943) is an investigational peptide-based triple hormone receptor agonist.

The molecule activates receptors for GIP, GLP-1, and glucagon, targeting multiple pathways involved in metabolic regulation.

Retatrutide is being studied as a once-weekly subcutaneous injection in clinical trials.

Pre-Filled Peptide Injection Pen

Retatrutide

30 mg

For subcutaneous use only